Clinical Trial Update: A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update assessing safety, tolerability, and pharmacokinetics of oral dabrafenib in children and adolescents with brain neoplasms; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• Dabrafenib (Dabrafenib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Neoplasms, Brain | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-11-24